Akari Therapeutics – Securities Investigation
Akari Therapeutics – Class Action Filed A class action lawsuit has been filed against Akari Therapeutics Plc (“Akari”) (NASDAQ: AKTX) and certain of its officers, on behalf of shareholders who purchased Akari securities between March 30, 2017 and May 11,... Read More →